Tag Archives: Tisch Cancer Institute

March, 2016

  • 9 March

    Researchers Discover New Therapeutic Targets for Myeloma

    Despite new therapies, Multiple Myeloma (MM) remains incurable causing most patients to ultimately develop drug resistance and succumb to the disease. The pursuit of drugs that inhibit cell cycle regulators especially cyclin-dependent kinases (CDKs), has been an intense focus of research in cancer. A new study by researchers at The …